Gene · 4607
NIH grants2,246
NIH grants whose papers are about the gene, through NIH's grant-paper links.
481 to 500 of 2,246
Download this page as JSON| Grant | Title | MYBPC3 papers | Newest fiscal year |
|---|---|---|---|
| U01TR003201 | Implementation of Whole Genome Sequencing as Screening in a Diverse Cohort of Healthy Infants | 1 | 2024 |
| U54AG062319 | Bioenergetic and Cardiometabolic Consequences of the Loss of Gonadal Function | 1 | 2024 |
| U54CA260543 | North Carolina Seronet Center for Excellence | 1 | 2024 |
| UM1DK126194 | Functional Interrogation of T2D-associated genes in human stem cell-derived models and mice | 1 | 2024 |
| ZIAHL006212 | Modifiers of elastin arteriopathy | 1 | 2024 |
| R01HL114770 | Functional consequences of FHC mutations in cardiac MyBPC | 19 | 2023 |
| R01HL128075 | Cardiomyopathy Genomes Project | 16 | 2023 |
| R01AR078001 | Slow myosin binding protein-C in skeletal muscle physiology | 11 | 2023 |
| T32GM007250 | Medical Scientist Training Program | 10 | 2023 |
| R01HL113084 | Frequency-dependent modulation of cardiac myofilament function in health/disease | 8 | 2023 |
| R01HL107046 | The interaction of myosin and the thin filament: how mutations cause allosteric dysfunction and their connection to genetic cardiomyopathy | 6 | 2023 |
| R01HL150953 | Cardiac Myosin-Binding Protein C: Molecular Mechanisms Governing Cardiac Contractility | 6 | 2023 |
| R01HL149870 | The Role of PRDM16 in Cardiac Development and Cardiomyopathy | 5 | 2023 |
| R35HL135827 | Leveraging Protein Kinase G-1 Nanodomain Control and Molecular Targeting to Enhance its Therapeutic Use Against Myocardial Disease | 5 | 2023 |
| RM1GM131981 | From proteins to cells to tissues: A multi-scale assessment of biomechanical regulation by the myosin molecular motor | 5 | 2023 |
| T32HL007822 | Post Graduate Studies in Cardiovascular Research | 5 | 2023 |
| UL1TR001422 | Northwestern University Clinical and Translational Science Institute (NUCATS) | 5 | 2023 |
| IK2CX001780 | Precision Cardio-Metabolic Phenotyping for Genetic Discovery and Risk Prediction | 4 | 2023 |
| R01HL149164 | Length-dependent activation in human myocardium | 4 | 2023 |
| UL1TR002553 | Duke CTSA | 4 | 2023 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4607/grants?page=25